Lucid Diligence Brief: InSilico Medicine and Lilly global partnership
Lucid Diligence Brief: InSilico Medicine and Lilly global partnership…
Lucid Diligence Brief: Pinnacle Medicines $89 million Series B
Lucid Diligence Brief: Pinnacle Medicines $89 million Series B Professional…
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly…
Lucid Diligence Brief: PRISM BioLab × Receptor.AI collaboration
Lucid Diligence Brief: PRISM BioLab × Receptor.AI collaboration Professional…
Lucid Diligence Brief: Turbine $25m Series B for virtual biology
Lucid Diligence Brief: Turbine $25m Series B for virtual biology Professional…
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on genetic epilepsies
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on…
Lucid Diligence Brief: Chai Discovery $130M Series B
Lucid Diligence Brief: Chai Discovery $130M Series B Professional audiences…
Lucid Diligence Brief: Insilico-TaiGen CKD anemia licensing deal
Lucid Diligence Brief: Insilico-TaiGen CKD anemia licensing deal Professional…
Neuroscience Today — November 26, 2025
This week’s Neuroscience news brings you the most important developments,…
Neuroscience Today — October 29, 2025
Get up to speed with this week’s neuroscience news, featuring clinical…
Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI
Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI Professional audiences…

